Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
62.9M
-
Shares change
-
+3.79M
-
Total reported value, excl. options
-
$29.2M
-
Value change
-
+$803K
-
Put/Call ratio
-
0
-
Number of buys
-
17
-
Number of sells
-
-25
-
Price
-
$0.47
Significant Holders of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) as of Q3 2022
64 filings reported holding SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share as of Q3 2022.
Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.9M shares
of 79.2M outstanding shares and own 79.38% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (13.4M shares), RA CAPITAL MANAGEMENT, L.P. (12.4M shares), Alyeska Investment Group, L.P. (8.1M shares), Bain Capital Life Sciences Investors, LLC (7.93M shares), K2 PRINCIPAL FUND, L.P. (5.56M shares), VANGUARD GROUP INC (3.34M shares), Artal Group S.A. (3M shares), BlackRock Inc. (2.84M shares), Laurion Capital Management LP (1.16M shares), and RENAISSANCE TECHNOLOGIES LLC (1.01M shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.